age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
75.37897
|
female
| 0
| 12
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 16
|
$11-$25k
| 0
| 14,949
| null | null | 21.5
|
white
| 22.199219
| 20
| 0.778931
| 0.646973
| 1
| 0
| 0
|
no
| 0.6
| 0.3
|
dnr after sadm
| 3
| 107
| 15.199219
| 110
| 20
| 37.79688
| 323.3125
| null | null | 0.799927
| 150
| 7.389648
| 105
| 26
| 1,350
| 4
| 1
|
no(M2 and SIP pres)
| 1
| 667
| 1
|
48.47598
|
male
| 0
| 15
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 12
|
>$50k
| 0
| 17,299
| null | null | 16.666656
|
white
| 17.296875
| 24
| 0.783936
| 0.713989
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.7
|
no dnr
| 15
| 67
| 6
| 80
| 16
| 35.59375
| null | 3.399902
| 0.799927
| 1
| 136
| null | 119
| 12
| null | 6
| 7
|
SIP>=30
| 7
| 211
| 1
|
69.33295
|
female
| 0
| 12
|
Colon Cancer
|
Cancer
| 2
| 9
| null | 0
| 21,897
| null | null | 19.5
|
hispanic
| 19.398438
| 23
| 0.772949
| 0.528931
| 1
| 0
| 0
|
metastatic
| 1
| 0.5
|
no dnr
| 12
| 69
| null | 68
| 22
| 36
| null | null | null | 1
| 139
| null | 172
| 12
| 5,450
| 3
| 0
|
no(M2 and SIP pres)
| 0
| 436
| 1
|
38.508
|
female
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$25-$50k
| 0
| 33,349
| null | null | 24.5
|
white
| 27.398438
| 46
| 0.844971
| 0.791992
| 1
| 0
| 0
|
no
| 0.95
| 0.95
|
no dnr
| 12
| 105
| 11.298828
| 77
| 26
| 38.09375
| 200
| 4.199219
| 0.299988
| 0.599976
| 140
| 7.379883
| 118
| 6
| 1,180
| null | 0
|
no(M2 and SIP pres)
| 0
| 1,074
| 0
|
69.75494
|
male
| 0
| 15
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 3
|
under $11k
| 0
| 31,384
| null | null | 22.333328
|
black
| 33.195313
| 43
| 0.605957
| 0.416992
| 1
| 0
| 0
|
no
| 0.6
| 0.5
|
no dnr
| 15
| 69
| 14.898438
| 63
| 6
| 38.19531
| 148.96875
| null | null | 4.299805
| 135
| 7.30957
| 87
| 57
| 2,143
| 0
| 1
|
no(M2 and SIP pres)
| 1
| 1,074
| 0
|
74.25598
|
female
| 0
| 23
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$25-$50k
| 0
| 39,642
| null | null | 26
|
white
| 29
| 25
| 0.680908
| 0.586914
| 1
| 1
| 0
|
no
| 0.75
| 0.65
|
no dnr
| 23
| 147
| 13.199219
| 69
| 8
| 36.89844
| 330
| null | null | 0.899902
| 141
| 7.449219
| 185
| 11
| 2,830
| null | 5
|
no(M2 and SIP pres)
| 5
| 1,074
| 0
|
64.12897
|
male
| 0
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$11-$25k
| 41
| 38,587
| null | null | 17.666656
|
white
| 29.296875
| 41
| 0.559937
| 0.44696
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 16
| 71
| 13.699219
| 111
| 10
| 39.19531
| 305
| 4.199219
| 0.199982
| 0.399963
| 140
| 7.399414
| 154
| 13
| 1,193
| null | 0
|
no(M2 and SIP pres)
| 0
| 1,074
| 0
|
57.43997
|
male
| 1
| 20
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 12
|
$25-$50k
| 0
| 128,232
| null | null | 43.333313
|
white
| 31.5
| 92
| 0.440979
| 0.320984
| 8
| 1
| 0
|
yes
| 0.8
| 0.7
|
dnr after sadm
| 19
| 97
| 3.899902
| 110
| 20
| 36.89844
| null | 2.599609
| 6.399414
| 1
| 140
| null | 157
| 16
| null | null | 1
|
<2 mo. follow-up
| 1
| 20
| 1
|
44.36099
|
female
| 1
| 10
|
Lung Cancer
|
Cancer
| 1
| 16
| null | 0
| 33,195
| null | null | 29
|
white
| 18.296875
| 23
| 0.72998
| 0.457947
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 10
| 49
| 10.199219
| 68
| 30
| 35.69531
| 110
| null | null | 4
| 147
| 7.359375
| 90
| 89
| 1,945
| null | 0
|
<2 mo. follow-up
| 0
| 10
| 1
|
56.00299
|
male
| 0
| 14
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 12
|
$25-$50k
| 0
| 15,116
| null | null | 8
|
white
| 17.296875
| 18
| 0.917969
| 0.861938
| 1
| 0
| 0
|
no
| 0.75
| 0.7
|
dnr after sadm
| 12
| 57
| 9.5
| 106
| 4
| 38.09375
| 240
| 3
| null | 1.299805
| 143
| 7.449219
| 148
| 36
| 1,400
| 2
| 0
|
<2 mo. follow-up
| 0
| 36
| 1
|
72.60797
|
male
| 0
| 43
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 0
| null | 0
| 60,769
| null | null | 15.75
|
white
| 26.796875
| 40
| 0.73291
| 0.649902
| 1
| 1
| 0
|
no
| 0.6
| 0.6
|
no dnr
| 43
| 49
| 17.5
| 120
| 12
| 35.69531
| 121.65625
| 3.599609
| 0.399963
| 2.799805
| 144
| 7.279297
| 121
| 57
| 560
| 0
| 1
|
no(M2 and SIP pres)
| 1
| 1,073
| 0
|
83.95294
|
female
| 0
| 22
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 9
|
under $11k
| 0
| 68,803
| null | null | 35.333313
|
white
| 31
| 43
| 0.523926
| 0.408997
| 4
| 1
| 0
|
no
| null | null |
no dnr
| 22
| 128
| 13.5
| 134
| 28
| 38.09375
| 206
| 3.699707
| 0.5
| 1.899902
| 142
| 7.319336
| 104
| 96
| 1,240
| null | 4
| null | 4
| 63
| 1
|
61.71899
|
male
| 0
| 8
|
Colon Cancer
|
Cancer
| 1
| 3
|
$11-$25k
| 0
| 10,202
| null | null | 10
|
white
| 15
| 19
| 0.8479
| 0.664917
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 8
| 106
| 5.899414
| 134
| 10
| 37
| 236.65625
| 2.299805
| 19.097656
| 1.399902
| 141
| 7.469727
| 224
| 56
| 3,990
| 1
| 0
|
no(M2 and SIP pres)
| 0
| 231
| 1
|
59.86298
|
male
| 0
| 10
|
Lung Cancer
|
Cancer
| 3
| 4
|
under $11k
| 0
| 7,594
| null | null | 7.5
|
black
| 27.5
| 28
| 0.462952
| 0.148987
| 1
| 0
| 0
|
metastatic
| 0.25
| 0.05
|
dnr after sadm
| 1
| 67
| 7.699219
| 70
| 20
| 36.09375
| null | null | null | 1.5
| 141
| null | 56
| 27
| 2,050
| null | 6
|
<2 mo. follow-up
| 6
| 15
| 1
|
70.75696
|
female
| 0
| 7
|
Colon Cancer
|
Cancer
| 1
| 8
|
under $11k
| 9
| 3,803
| null | null | 7.5
|
black
| 21
| 32
| 0.711914
| 0.430969
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 7
| 55
| 18.097656
| 118
| 30
| 38.29688
| null | 1.799805
| 0.5
| 3.399902
| 131
| null | 299
| 27
| 0
| null | 6
|
<2 mo. follow-up
| 6
| 41
| 1
|
30.834
|
female
| 0
| 37
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
| null | 0
| 65,783
| 42,571.5312
| 38,567
| 17
|
black
| 18.296875
| 19
| 0.932983
| 0.907959
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 37
| 67
| 10.398438
| 60
| 20
| 38.29688
| 98.32812
| null | null | 1.699951
| 141
| 7.509766
| 134
| 27
| 2,075
| 2
| 5
|
SIP>=30
| 5
| 1,070
| 0
|
67.24695
|
male
| 0
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 6
|
$11-$25k
| 0
| 29,237
| null | null | 28.5
|
black
| 20
| 18
| 0.839966
| 0.784912
| 2
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 10
| 59
| 24.699219
| 60
| 24
| 35.79688
| null | 3.599609
| 1.099854
| 2.299805
| 141
| null | 102
| 58
| 1,650
| null | 1
|
adl>=4 (>=5 if sur)
| 1
| 699
| 1
|
25.114
|
female
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 15
|
$11-$25k
| 0
| 40,468
| null | null | 17
|
black
| 33
| 36
| 0.776978
| 0.704956
| 5
| 0
| 0
|
no
| 0.75
| 0.7
|
no dnr
| 12
| 104
| 0.199982
| 125
| 22
| 36.89844
| null | 2.299805
| 0.699951
| 0.5
| 136
| null | 113
| 6
| 5,000
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,069
| 0
|
71.96997
|
female
| 1
| 5
|
Coma
|
Coma
| 2
| null | null | 61
| 18,530
| null | null | 17
|
white
| 19.898438
| 43
| 0.392944
| 0.319946
| 4
| 1
| 0
|
no
| null | null |
dnr after sadm
| 1
| 38
| 8
| 70
| 16
| 35.79688
| null | 4.699219
| 0.699951
| 1.199951
| 135
| null | 94
| 21
| 3,050
| null | null |
<2 mo. follow-up
| 2.836426
| 5
| 1
|
52.26599
|
male
| 0
| 19
|
Colon Cancer
|
Cancer
| 1
| 20
|
>$50k
| 0
| 18,529
| null | null | 14.666664
|
asian
| 37.195313
| 22
| 0.404968
| 0.106995
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 19
| 77
| 10.398438
| 60
| 20
| 35.59375
| null | null | null | 1.699951
| 135
| null | 125
| 33
| 1,150
| null | 0
|
no(M2 and SIP pres)
| 0
| 1,069
| 0
|
25.96599
|
female
| 0
| 8
|
Colon Cancer
|
Cancer
| 1
| 14
|
$11-$25k
| 0
| 14,354
| null | null | 10
|
black
| 14.798828
| 16
| 0.895996
| 0.761963
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 8
| 114
| 9.099609
| 53
| 28
| 38.19531
| 225.6875
| 3.899902
| 0.399963
| 1.099854
| 139
| 7.399414
| 108
| 18
| 2,700
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 203
| 1
|
37.25098
|
male
| 0
| 12
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 14
|
$11-$25k
| 0
| 24,578
| null | null | 25
|
white
| 23.398438
| 27
| 0.873901
| 0.790894
| 1
| 0
| 0
|
yes
| 0.8
| 0.7
|
no dnr
| 12
| 80
| 6.599609
| 70
| 20
| 36.79688
| 315.375
| null | null | 1.199951
| 139
| 7.319336
| 95
| 23
| 1,150
| 0
| 1
|
no(M2 and SIP pres)
| 1
| 540
| 1
|
67.14899
|
female
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| 14
| null | 0
| 7,070
| null | null | 12
|
white
| 17.796875
| 16
| 0.685913
| 0.392944
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 5
| 100
| 6.5
| 80
| 25
| 36
| null | 3.299805
| null | 1.299805
| 146
| null | 88
| 24
| 1,500
| 4
| 1
|
no(M2 and SIP pres)
| 1
| 291
| 1
|
57.19098
|
male
| 0
| 11
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 10
|
$11-$25k
| 0
| 18,074
| null | null | 14.5
|
black
| 25.898438
| 36
| 0.834961
| 0.730957
| 1
| 0
| 0
|
no
| 0.95
| 0.95
|
no dnr
| 11
| 100
| 7.799805
| 70
| 20
| 36.09375
| null | 3.099609
| 0.5
| 1.299805
| 144
| null | 103
| 16
| null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,069
| 0
|
67.56494
|
male
| 0
| 11
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 14
|
$25-$50k
| 0
| 11,944
| null | null | 13
|
white
| 18
| 10
| 0.873901
| 0.790894
| 1
| 1
| 0
|
no
| 0.6
| 0.6
|
no dnr
| 11
| 63
| 7.299805
| 80
| 20
| 37.09375
| 458.3125
| null | null | 1.599854
| 142
| 7.359375
| 111
| 21
| 1,300
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,069
| 0
|
51.88498
|
female
| 1
| 9
|
Lung Cancer
|
Cancer
| 1
| 12
|
$11-$25k
| 0
| 35,326
| null | null | 33
|
white
| 20
| 23
| 0.677979
| 0.381958
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 9
| 63
| 29.097656
| 80
| 7
| 38
| 214
| null | null | 3.199707
| 142
| 7.399414
| 111
| 35
| 3,336
| null | 1
|
<2 mo. follow-up
| 1
| 9
| 1
|
82.53497
|
female
| 0
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
| null | 0
| 75,513
| null | null | 22.666656
|
white
| 19.699219
| 37
| 0.691895
| 0.599976
| 13
| 0
| 0
|
yes
| 0.25
| 0.15
|
dnr after sadm
| 1
| 65
| 14.298828
| 106
| 24
| 36.39844
| 248
| null | null | 0.799927
| 136
| 7.359375
| 105
| 21
| 1,100
| null | 6
|
<2 mo. follow-up
| 6
| 19
| 1
|
84.23499
|
male
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 0
| 18,640
| null | null | 13.5
|
black
| 28
| 52
| 0.650879
| 0.550903
| 1
| 0
| 0
|
no
| 0.25
| 0.2
|
dnr after sadm
| 2
| 119
| 5.699219
| 114
| 27
| 36.59375
| 140.8125
| null | 15
| 5
| 154
| 7.479492
| 104
| 78
| 3,560
| null | 0
|
no(M2 and SIP pres)
| 0
| 99
| 1
|
61.22699
|
female
| 0
| 17
|
Lung Cancer
|
Cancer
| 1
| 18
|
>$50k
| 0
| 25,452
| null | null | 8.666664
|
white
| 21
| 19
| 0.630981
| 0.31897
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 17
| 75
| 26.199219
| 120
| 48
| 38.29688
| 185
| null | null | 1.599854
| 138
| 7.449219
| 123
| 20
| 2,190
| 0
| 0
|
<2 mo. follow-up
| 0
| 40
| 1
|
56.797
|
male
| 1
| 4
|
MOSF w/Malig
|
ARF/MOSF
| 2
| null | null | 0
| 71,320
| null | null | 36
|
black
| 36.09375
| 89
| 0.184998
| 0.095993
| 28
| 0
| 0
|
metastatic
| 0.1
| 0.05
|
dnr after sadm
| 2
| 73
| 13.5
| 124
| 36
| 39
| 211.40625
| 2.299805
| 0.599976
| 0.399963
| 134
| 7.459961
| 123
| 5
| 3,425
| null | null |
<2 mo. follow-up
| 2.660156
| 4
| 1
|
63.655
|
male
| 1
| 41
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 9
|
$11-$25k
| 37
| 168,511
| 112,099.5
| 88,988
| 31.5
|
white
| 30
| 44
| 0.280945
| 0.171997
| 12
| 0
| 0
|
metastatic
| 0.2
| 0.2
|
dnr after sadm
| 33
| 65
| 4.399414
| 106
| 28
| 36.69531
| 340
| 2.599609
| 18.898438
| 2.5
| 134
| 7.149414
| 114
| 67
| 75
| null | 1
|
<2 mo. follow-up
| 1
| 41
| 1
|
63.01199
|
female
| 1
| 47
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 4
|
under $11k
| 0
| 266,672
| null | null | 44.75
|
white
| 31.097656
| 45
| 0.536987
| 0.421997
| 10
| 0
| 0
|
yes
| 0.9
| 0.9
|
dnr after sadm
| 38
| 0
| 11.5
| 0
| 0
| 38.89844
| 151.65625
| null | null | 2
| 137
| 7.239258
| 203
| 35
| 4,135
| null | 4
|
<2 mo. follow-up
| 4
| 47
| 1
|
62.20099
|
male
| 0
| 3
|
Colon Cancer
|
Cancer
| 1
| 12
| null | 0
| null | null | null | 4
|
white
| 15.5
| 16
| 0.840942
| 0.650879
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 3
| 72
| 6.5
| 54
| 22
| 35.79688
| null | null | null | 2.099609
| 135
| null | 100
| 79
| 1,000
| null | null |
no(M2 and SIP pres)
| 1.689697
| 958
| 1
|
47.95297
|
male
| 1
| 26
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 12
|
under $11k
| 0
| 124,393
| null | null | 37.25
|
white
| 30.296875
| 72
| 0.685913
| 0.518921
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 22
| 113
| 23
| 106
| 10
| 36
| null | 2.099609
| 4
| 1.099854
| 137
| null | 94
| 13
| 990
| null | 0
|
<2 mo. follow-up
| 0
| 26
| 1
|
82.06995
|
female
| 0
| 12
|
Lung Cancer
|
Cancer
| 3
| null |
$11-$25k
| 9
| 9,039
| null | null | 7.5
|
white
| 22.296875
| 27
| 0.491943
| 0.171997
| 1
| 0
| 1
|
metastatic
| 0.7
| 0.1
|
dnr before sadm
| 0
| 119
| 14.5
| 100
| 24
| 35.59375
| null | null | 0.399963
| 0.599976
| 133
| null | 160
| 9
| 3,700
| null | 3
|
<2 mo. follow-up
| 3
| 14
| 1
|
62.28299
|
female
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 8
|
under $11k
| 0
| 6,597
| null | null | 8
|
white
| 16.097656
| 12
| 0.902954
| 0.836914
| 1
| 0
| 0
|
no
| 0.99
| 0.95
|
no dnr
| 9
| 100
| 17.296875
| 60
| 29
| 38.79688
| 217.125
| null | null | 0.799927
| 137
| 7.459961
| 105
| 10
| 5,710
| 1
| 2
|
SIP>=30
| 2
| 1,060
| 0
|
65.70294
|
male
| 0
| 87
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| null | null | 44
| 272,666
| 192,386.125
| 160,300
| 35.25
| null | 22.097656
| 29
| 0.717896
| 0.560913
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 87
| 97
| 17.5
| 65
| 8
| 38
| 362.8125
| null | null | 5.5
| 141
| 7.439453
| 274
| 110
| 625
| null | null |
Coma or Intub
| 2.80957
| 773
| 1
|
62.43399
|
male
| 0
| 6
|
Colon Cancer
|
Cancer
| 1
| 12
|
$11-$25k
| 0
| 9,179
| null | null | 8
|
white
| 14.199219
| 2
| 0.85498
| 0.678955
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.5
|
no dnr
| 6
| 119
| 12.199219
| 66
| 24
| 38.59375
| 368
| 2.599609
| 0.799927
| 1.299805
| 133
| 7.449219
| 87
| 25
| 6,110
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 233
| 1
|
79.98096
|
female
| 1
| 3
|
Coma
|
Coma
| 2
| null | null | 100
| 21,247
| null | null | 16
|
other
| 76.6875
| 73
| 0
| 0
| 4
| 0
| 0
|
no
| null | null |
dnr after sadm
| 2
| 36
| 57.796875
| 224
| 32
| 36.09375
| 41
| 2.099609
| 0.699951
| 1.799805
| 135
| 7.30957
| 123
| 50
| 580
| null | null |
<2 mo. follow-up
| 1.878662
| 3
| 1
|
52.51498
|
female
| 0
| 25
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 13
| null | 0
| 67,737
| null | null | 24.25
|
white
| 23.898438
| 54
| 0.834961
| 0.778931
| 2
| 0
| 0
|
no
| 0.85
| 0.8
|
no dnr
| 25
| 55
| 65.6875
| 140
| 21
| 38.09375
| 133.3125
| 1.599854
| 0.799927
| 1.5
| 142
| 7.429688
| 136
| 22
| 1,400
| null | 3
|
adl>=4 (>=5 if sur)
| 3
| 226
| 1
|
84.07697
|
female
| 1
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 7
|
under $11k
| 9
| 35,499
| null | null | 32
|
black
| 30.398438
| 47
| 0.553955
| 0.440979
| 1
| 0
| 0
|
no
| 0.75
| 0.75
|
no dnr
| 10
| 87
| 5.899414
| 74
| 16
| 36.59375
| null | null | 1
| 1.099854
| 140
| null | 126
| 9
| 4,500
| null | 5
|
<2 mo. follow-up
| 5
| 10
| 1
|
80.16394
|
male
| 1
| 38
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 3
|
under $11k
| 9
| 177,245
| null | null | 27.25
|
other
| 30.699219
| 54
| 0.355957
| 0.238983
| 32
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 22
| 51
| 16.898438
| 116
| 34
| 39.59375
| 124.4375
| null | 3.399902
| 1.599854
| 136
| 7.399414
| 249
| 33
| 2,655
| null | 7
|
<2 mo. follow-up
| 7
| 38
| 1
|
50.03699
|
male
| 1
| 21
|
Coma
|
Coma
| 1
| 14
|
$11-$25k
| 55
| 17,795
| null | null | 12.666664
|
white
| 24.898438
| 27
| 0.55896
| 0.491943
| 1
| 0
| 0
|
no
| 0.5
| 0.25
|
dnr after sadm
| 2
| 73
| 11.398438
| 110
| 46
| 38.69531
| 182.84375
| null | 0.399963
| 0.399963
| 131
| 7.519531
| 148
| 15
| 2,180
| null | 5
|
<2 mo. follow-up
| 5
| 21
| 1
|
72.51196
|
male
| 0
| 24
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 16
|
$11-$25k
| 0
| 6,038
| null | null | 27
|
black
| 22.199219
| 37
| 0.797974
| 0.674927
| 1
| 0
| 0
|
no
| 0.4
| 0.35
|
no dnr
| 24
| 109
| 10.099609
| 124
| 33
| 38
| 164.4375
| 3.099609
| 1.199951
| 0.5
| 137
| 7.459961
| 130
| 14
| 3,555
| null | 0
|
no(M2 and SIP pres)
| 0
| 1,056
| 0
|
67.45496
|
male
| 0
| 13
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
| null | 0
| 37,913
| null | null | 9.5
|
white
| 17.796875
| 21
| 0.876953
| 0.795898
| 1
| 0
| 0
|
no
| 0.85
| 0.75
|
no dnr
| 13
| 112
| 10.599609
| 54
| 8
| 38.29688
| null | 2.699707
| null | 0.799927
| 138
| 7.429688
| 146
| 4
| 3,200
| 0
| 1
|
<2 mo. follow-up
| 1
| 24
| 1
|
44.63498
|
male
| 0
| 7
|
Lung Cancer
|
Cancer
| 1
| 16
|
>$50k
| 0
| 14,703
| null | null | 8.5
|
white
| 9.298828
| 5
| 0.858887
| 0.685913
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.7
|
no dnr
| 7
| 116
| 14.298828
| 112
| 26
| 36.39844
| 186.65625
| 2.399902
| 0.699951
| 1.399902
| 140
| 7.489258
| 279
| 31
| 3,025
| 0
| 4
|
no(M2 and SIP pres)
| 4
| 258
| 1
|
76.16394
|
male
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 3
|
under $11k
| 9
| 23,055
| null | null | 17
|
black
| 21.898438
| 23
| 0.774902
| 0.702881
| 1
| 0
| 0
|
no
| 0.7
| 0.6
|
no dnr
| 9
| 62
| 5
| 104
| 23
| 37.89844
| 91.25
| 2.099609
| 9.398438
| 1
| 147
| 7.539062
| 424
| 30
| 1,790
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,055
| 0
|
46.26099
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 7
|
under $11k
| 0
| 18,417
| null | null | 5
|
white
| 15.398438
| 18
| 0.934937
| 0.888916
| 1
| 0
| 0
|
no
| 0.85
| 0.8
|
no dnr
| 7
| 103
| 12.398438
| 112
| 24
| 36
| 414.25
| 3.199707
| 0.399963
| 1.199951
| 141
| 7.429688
| 137
| 24
| 2,300
| null | 3
|
no(M2 and SIP pres)
| 3
| 1,056
| 0
|
62.543
|
female
| 1
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 20
| null | 0
| 75,022
| null | null | 42
|
white
| 32.796875
| 56
| 0.564941
| 0.453979
| 14
| 0
| 0
|
no
| 0.6
| 0.5
|
dnr after sadm
| 5
| 120
| 7.699219
| 80
| 24
| 35.5
| 200
| null | 0.699951
| 1.299805
| 140
| 7.429688
| 118
| 26
| 2,500
| null | 6
|
<2 mo. follow-up
| 6
| 10
| 1
|
37.314
|
male
| 1
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 11
|
under $11k
| 0
| 51,971
| null | null | 55
|
white
| 32.296875
| 46
| 0.781982
| 0.710938
| 1
| 0
| 0
|
no
| 0.4
| 0.3
|
no dnr
| 6
| 124
| 16.097656
| 106
| 11
| 37.59375
| 356.625
| null | 0.5
| 1.199951
| 141
| 7.389648
| 116
| 12
| 1,555
| null | 0
|
<2 mo. follow-up
| 0
| 6
| 1
|
66.53796
|
male
| 1
| 23
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 15
|
$11-$25k
| 0
| 188,481
| null | null | 47.333313
|
white
| 36.59375
| 61
| 0.247986
| 0.144989
| 15
| 0
| 0
|
yes
| 0.5
| 0.3
|
dnr after sadm
| 21
| 65
| 17.898438
| 20
| 50
| 38.79688
| 226.65625
| 2.799805
| 0.399963
| 0.799927
| 145
| 7.439453
| 176
| 8
| 2,150
| null | 0
|
<2 mo. follow-up
| 0
| 23
| 1
|
63.784
|
male
| 0
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
$11-$25k
| 0
| 21,519
| null | null | 22
|
white
| 15.298828
| 22
| 0.893921
| 0.856934
| 2
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 6
| 125
| 68.5
| 134
| 28
| 35.5
| 190
| 2.899902
| 0.599976
| 0.899902
| 144
| 7.379883
| 184
| 20
| 2,880
| 1
| 6
|
no(M2 and SIP pres)
| 6
| 1,054
| 0
|
69.16394
|
male
| 1
| 87
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 7
|
under $11k
| 44
| 217,056
| 145,305
| 126,986
| 39.75
|
white
| 25.097656
| 37
| 0.46698
| 0.347961
| 6
| 1
| 0
|
yes
| 0.2
| 0.2
|
dnr after sadm
| 85
| 91
| 24
| 76
| 24
| 36.29688
| 171.40625
| null | 1.099854
| 3.299805
| 131
| 7.449219
| 168
| 55
| 4,435
| null | 0
|
adl>=4 (>=5 if sur)
| 0
| 87
| 1
|
67.49298
|
male
| 0
| 6
|
Colon Cancer
|
Cancer
| 1
| 15
|
$25-$50k
| 0
| 7,680
| null | null | 12
|
white
| 10.599609
| 10
| 0.883911
| 0.736938
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 6
| 105
| 12.699219
| 160
| 26
| 38.59375
| 125
| 2.699707
| 0.699951
| 0.599976
| 141
| 7.459961
| 222
| 14
| 1,785
| 1
| 4
|
no(M2 and SIP pres)
| 4
| 298
| 1
|
58.50198
|
male
| 1
| 4
|
MOSF w/Malig
|
ARF/MOSF
| 1
| null | null | 0
| 42,141
| null | null | 44
|
white
| 43.195313
| 115
| 0.109985
| 0.046997
| 11
| 0
| 0
|
yes
| 0.05
| 0
|
dnr after sadm
| 4
| 61
| 0.199982
| 186
| 36
| 38.59375
| 275.5
| 1.899902
| 1
| 1.699951
| 140
| 7.419922
| 200
| 34
| 650
| null | null |
<2 mo. follow-up
| 1.979981
| 4
| 1
|
73.26794
|
male
| 1
| 59
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 7
|
under $11k
| 0
| 225,766
| 150,638.875
| 123,097
| 35.75
|
white
| 25.097656
| 32
| 0.68396
| 0.590942
| 16
| 0
| 0
|
no
| 0.05
| 0.02
|
dnr after sadm
| 49
| 87
| 1.799805
| 120
| 22
| 37.79688
| 314.25
| null | 0.799927
| 0.799927
| 136
| 7.509766
| 101
| 8
| 3,050
| null | 1
|
<2 mo. follow-up
| 1
| 59
| 1
|
69.28998
|
male
| 1
| 6
|
Coma
|
Coma
| 2
| 12
|
$25-$50k
| 89
| 23,434
| null | null | 26
|
white
| 16
| 7
| 0.402954
| 0.328979
| 3
| 1
| 0
|
no
| 0
| 0
|
dnr after sadm
| 2
| 107
| 13.898438
| 104
| 20
| 36.19531
| 284
| 3.799805
| 0.599976
| 1.199951
| 139
| 7.359375
| 150
| 28
| null | null | 0
|
<2 mo. follow-up
| 0
| 6
| 1
|
72.36395
|
male
| 1
| 63
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 16
|
>$50k
| 89
| 149,405
| 94,173.8125
| 91,506
| 26.25
|
white
| 22
| 41
| 0.271973
| 0.164978
| 13
| 0
| 0
|
yes
| 0.5
| 0.3
|
dnr after sadm
| 63
| 112
| 13.398438
| 114
| 12
| 36.79688
| 182
| null | null | 1.599854
| 144
| 7.329102
| 69
| 30
| 4,415
| null | 4
| null | 4
| 63
| 1
|
42.21198
|
male
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
| null | 0
| 14,313
| null | null | 10
|
white
| 16.597656
| 8
| 0.93396
| 0.886963
| 1
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 8
| 111
| 13.898438
| 116
| 25
| 38.09375
| 151
| 3
| 0.399963
| 3.599609
| 137
| 7.379883
| 244
| 54
| 3,265
| 7
| 0
|
no(M2 and SIP pres)
| 0
| 636
| 1
|
56.48199
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 50,879
| null | null | 29
|
white
| 18.097656
| 35
| 0.899902
| 0.831909
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 5
| 75
| 3.799805
| 74
| 18
| 36.69531
| null | 3.699707
| 0.599976
| 2.099609
| 140
| null | 88
| 13
| 4,350
| null | null |
<2 mo. follow-up
| 1.866455
| 18
| 1
|
25.64499
|
male
| 0
| 20
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 14
|
$11-$25k
| 0
| 49,765
| null | null | 22
|
white
| 28.699219
| 50
| 0.916992
| 0.859985
| 3
| 0
| 0
|
no
| 0.4
| 0.4
|
no dnr
| 20
| 70
| 13
| 70
| 16
| 35
| null | 2.899902
| 1.199951
| 1.099854
| 133
| null | 120
| 61
| 1,400
| null | 0
|
no(M2 and SIP pres)
| 0
| 1,047
| 0
|
67.89294
|
male
| 0
| 22
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
| null | 0
| 65,432
| null | null | 34.333313
|
white
| 25.398438
| 53
| 0.780884
| 0.650879
| 1
| 0
| 0
|
no
| 0.78
| 0.7
|
no dnr
| 22
| 71
| 25.5
| 100
| 20
| 37.69531
| null | null | null | 1.799805
| 135
| null | 58
| 17
| null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,046
| 0
|
70.57397
|
male
| 0
| 11
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$25-$50k
| 0
| 22,068
| null | null | 10.5
|
white
| 13.599609
| 20
| 0.904907
| 0.839966
| 1
| 0
| 0
|
no
| 0.95
| 0.75
|
no dnr
| 11
| 81
| 9.898438
| 130
| 24
| 37.89844
| 253.3125
| 2.299805
| 0.5
| 0.899902
| 139
| 7.40918
| 143
| 8
| 4,870
| 0
| 2
|
no(M2 and SIP pres)
| 2
| 1,046
| 0
|
60.22998
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 14
|
>$50k
| 0
| 12,106
| null | null | 6
|
white
| 16
| 22
| 0.907959
| 0.844971
| 1
| 1
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 7
| 131
| 6.899414
| 54
| 14
| 37.59375
| 157.5
| null | null | 0.899902
| 138
| 7.389648
| 121
| 7
| 6,915
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,046
| 0
|
50.37399
|
female
| 0
| 38
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
$25-$50k
| 0
| 220,001
| 143,696.125
| 117,379
| 20.25
|
black
| 23.796875
| 30
| 0.793945
| 0.725952
| 36
| 1
| 0
|
no
| 0.9
| 0.75
|
no dnr
| 38
| 107
| 15
| 120
| 44
| 38.29688
| 63.32812
| null | null | 0.699951
| 138
| 7.379883
| 69
| 7
| 1,270
| null | 2
|
no(M2 and SIP pres)
| 2
| 1,045
| 0
|
28.709
|
female
| 0
| 4
|
Colon Cancer
|
Cancer
| 1
| 15
|
$25-$50k
| 0
| 2,712
| null | null | 10
|
white
| 18.296875
| 17
| 0.859985
| 0.688965
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.15
|
no dnr
| 4
| 109
| 6.699219
| 96
| 22
| 35.79688
| 352
| null | null | 11.599609
| 138
| 7.429688
| 152
| 89
| 0
| 0
| 0
| null | 0
| 170
| 1
|
69.91095
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 3,738
| null | null | 5.5
|
white
| 24.097656
| 41
| 0.792969
| 0.667969
| 1
| 1
| 0
|
no
| 0.95
| 0.75
|
no dnr
| 7
| 121
| 14.699219
| 100
| 8
| 36.09375
| 380
| 2
| 0.599976
| 0.699951
| 135
| 7.379883
| 274
| 8
| 1,270
| null | null |
<2 mo. follow-up
| 2.931152
| 56
| 1
|
23.10699
|
female
| 0
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 0
| 24,572
| null | null | 17.5
|
black
| 17.898438
| 26
| 0.94397
| 0.922974
| 1
| 1
| 0
|
no
| 0.95
| 0.95
|
no dnr
| 8
| 73
| 7.599609
| 60
| 16
| 39.19531
| null | null | null | null | 138
| null | 143
| 6
| 1,390
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,045
| 0
|
69.54095
|
female
| 1
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 100
| 58,201
| null | null | 53
|
white
| 56.09375
| 95
| 0
| 0
| 2
| 0
| 0
|
no
| 0
| 0
|
dnr after sadm
| 5
| 71
| 12.798828
| 106
| 24
| 36.89844
| 409.5
| null | null | 1.5
| 129
| 7.5
| 181
| 37
| 4,600
| null | null |
<2 mo. follow-up
| 2.704102
| 5
| 1
|
81.68396
|
male
| 0
| 26
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 12
|
$11-$25k
| 0
| 53,116
| null | null | 16
|
white
| 26.296875
| 50
| 0.576904
| 0.382996
| 7
| 0
| 0
|
no
| 0.8
| 0.75
|
no dnr
| 26
| 130
| 10.199219
| 108
| 20
| 36.69531
| null | null | 0.5
| 0.899902
| 141
| null | 122
| 16
| 5,900
| null | 0
|
no(M2 and SIP pres)
| 0
| 363
| 1
|
65.53894
|
male
| 0
| 6
|
Colon Cancer
|
Cancer
| 2
| 8
|
under $11k
| 0
| 5,489
| null | null | 7
|
black
| 19.597656
| 17
| 0.778931
| 0.537964
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.2
|
no dnr
| 6
| 139
| 43.09375
| 120
| 35
| 36.19531
| 264
| null | null | 0.899902
| 141
| 7.329102
| 170
| 14
| 2,325
| null | 5
| null | 5
| 191
| 1
|
83.99695
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 16
| null | 0
| 9,379
| null | null | 15
|
white
| 19.199219
| 31
| 0.80896
| 0.689941
| 1
| 0
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 5
| 70
| 7.5
| 100
| 16
| 36
| 423.75
| null | null | 1.299805
| 139
| 7.449219
| 228
| 14
| 2,380
| null | 3
|
no(M2 and SIP pres)
| 3
| 349
| 1
|
66.24194
|
female
| 0
| 14
|
Lung Cancer
|
Cancer
| 2
| 15
|
under $11k
| 0
| 21,273
| null | null | 12.666664
|
white
| 25.296875
| 39
| 0.50293
| 0.181976
| 1
| 0
| 0
|
metastatic
| 0.85
| 0.78
|
no dnr
| 14
| 109
| 8.099609
| 126
| 24
| 38.29688
| 368
| null | null | 0.699951
| 133
| 7.379883
| 131
| 6
| 865
| null | null |
<2 mo. follow-up
| 3.279297
| 27
| 1
|
51.46597
|
female
| 0
| 45
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 8
|
$25-$50k
| 0
| 98,005
| null | null | 14.25
|
white
| 19.597656
| 23
| 0.730957
| 0.578979
| 19
| 0
| 0
|
yes
| 1
| 1
|
no dnr
| 45
| 125
| 9.398438
| 120
| 24
| 38.59375
| null | 1.799805
| 0.799927
| 0.599976
| 135
| null | 148
| 31
| null | null | 1
|
no(M2 and SIP pres)
| 1
| 1,040
| 0
|
63.47998
|
female
| 1
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
| null | 26
| 64,614
| null | null | 33
|
white
| 26.796875
| 47
| 0.589966
| 0.480957
| 16
| 0
| 0
|
no
| 0.1
| 0.05
|
dnr after sadm
| 5
| 122
| 11.298828
| 70
| 10
| 35.29688
| 428.5625
| null | 2
| 2.899902
| 141
| 7.289062
| 126
| 66
| 2,875
| null | 0
|
<2 mo. follow-up
| 0
| 5
| 1
|
72.10699
|
male
| 1
| 126
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 9
|
$11-$25k
| 0
| 412,406
| 299,965.75
| 246,904
| 31.75
|
white
| 49
| 58
| 0.140991
| 0.032997
| 1
| 0
| 0
|
no
| 0.7
| 0.6
|
dnr after sadm
| 93
| 80
| 20.5
| 118
| 16
| 36
| null | 3.599609
| 0.399963
| 0.899902
| 136
| null | 110
| 22
| 5,650
| null | 0
|
adl>=4 (>=5 if sur)
| 0
| 126
| 1
|
24.05699
|
female
| 0
| 23
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$11-$25k
| 0
| 87,463
| null | null | 30
|
white
| 19.398438
| 14
| 0.92395
| 0.895996
| 4
| 0
| 0
|
no
| 0.7
| 0.7
|
no dnr
| 23
| 58
| 31.5
| 140
| 35
| 38
| 146.9375
| 2
| 1.299805
| 4
| 146
| 7.349609
| 108
| 67
| 5
| null | 0
|
no(M2 and SIP pres)
| 0
| 1,037
| 0
|
77.30896
|
male
| 1
| 9
|
Coma
|
Coma
| 1
| 9
| null | 61
| 31,303
| null | null | 32
|
white
| 22.199219
| 43
| 0.33197
| 0.259949
| 1
| 1
| 0
|
no
| 0.05
| 0.02
|
dnr after sadm
| 6
| 149
| 1.599854
| 124
| 25
| 37.79688
| 177.5
| null | 0.799927
| 1.299805
| 142
| 7.429688
| 159
| 53
| 3,615
| null | null |
<2 mo. follow-up
| 2.285156
| 9
| 1
|
22.116
|
female
| 1
| 30
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
$11-$25k
| 0
| 195,681
| 59,831.8125
| 110,839
| 52.5
|
black
| 42.09375
| 105
| 0.666992
| 0.569946
| 1
| 0
| 0
|
no
| 0.15
| 0.15
|
dnr after sadm
| 30
| 64
| 16.199219
| 126
| 40
| 36.39844
| 147.5
| null | null | 0.799927
| 149
| 7.399414
| 168
| 20
| 1,245
| null | 0
|
<2 mo. follow-up
| 0
| 30
| 1
|
61.487
|
male
| 0
| 39
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 8
|
$11-$25k
| 44
| 99,152
| null | null | 24
|
black
| 31.699219
| 47
| 0.369995
| 0.251953
| 22
| 1
| 0
|
no
| 0.2
| 0.15
|
no dnr
| 39
| 80
| 5.299805
| 76
| 12
| 35.59375
| null | null | 0.399963
| 1
| 142
| null | 126
| 17
| null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 431
| 1
|
43.65799
|
female
| 0
| 24
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$25-$50k
| 0
| 42,531
| null | null | 13.666664
|
white
| 30.199219
| 21
| 0.790894
| 0.7229
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 24
| 53
| 12.798828
| 140
| 10
| 38.29688
| 280
| 3.099609
| 11.5
| 1.099854
| 139
| 7.509766
| 156
| 39
| 1,505
| null | 0
| null | 0
| 1,036
| 0
|
61.465
|
male
| 1
| 53
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 15
|
$11-$25k
| 0
| 261,018
| 170,933.125
| 151,400
| 38
|
white
| 27.199219
| 34
| 0.667969
| 0.571899
| 5
| 0
| 0
|
yes
| 1
| 1
|
no dnr
| 53
| 81
| 13.398438
| 76
| 20
| 36.59375
| null | null | null | 2.5
| 152
| null | 178
| 55
| 1,850
| null | 0
|
<2 mo. follow-up
| 0
| 53
| 1
|
56.23798
|
female
| 1
| 33
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 17
|
$25-$50k
| 0
| 52,458
| null | null | 19
|
white
| 23.699219
| 39
| 0.651978
| 0.552979
| 1
| 0
| 0
|
metastatic
| 0.15
| 0.05
|
dnr after sadm
| 27
| 80
| 8.099609
| 76
| 20
| 35.5
| null | 4.099609
| 0.399963
| 0.299988
| 138
| null | 91
| 14
| 1,400
| null | 6
|
<2 mo. follow-up
| 6
| 33
| 1
|
77.22095
|
female
| 1
| 4
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 12
|
under $11k
| 26
| 59,938
| null | null | 40
|
white
| 57.796875
| 81
| 0
| 0
| 15
| 0
| 0
|
metastatic
| 0.02
| 0.02
|
dnr after sadm
| 4
| 116
| 18.699219
| 146
| 11
| 38
| 270
| 3.199707
| 0.399963
| 1.299805
| 136
| 7.459961
| 165
| 23
| 2,580
| null | 1
|
<2 mo. follow-up
| 1
| 4
| 1
|
78.04797
|
female
| 1
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
| null | 26
| 112,976
| null | null | 56
|
black
| 45.5
| 86
| 0.044998
| 0.012999
| 12
| 0
| 1
|
no
| 0
| 0
|
no dnr
| 4
| 95
| 6.399414
| 94
| 20
| 37
| null | null | 0.599976
| 1
| 140
| null | 115
| 4
| 3,250
| null | 0
|
<2 mo. follow-up
| 0
| 4
| 1
|
55.57797
|
male
| 0
| 23
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
>$50k
| 0
| 103,968
| null | null | 40.333313
|
white
| 29.199219
| 45
| 0.761963
| 0.685913
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 23
| 0
| 15.699219
| 0
| 0
| 37.09375
| 159.15625
| null | 0.899902
| 1.199951
| 127
| 7.379883
| 249
| 20
| 420
| null | 6
|
no(M2 and SIP pres)
| 6
| 1,034
| 0
|
46.73499
|
male
| 0
| 4
|
Colon Cancer
|
Cancer
| 1
| 13
|
$11-$25k
| 0
| 3,267
| null | null | 11
|
white
| 13.298828
| 9
| 0.884888
| 0.73999
| 1
| 0
| 0
|
metastatic
| 0.65
| 0.35
|
no dnr
| 4
| 69
| 9.199219
| 80
| 26
| 36.5
| 260
| null | null | 6.799805
| 130
| 7.339844
| 100
| 82
| 0
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 100
| 1
|
64.047
|
male
| 1
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 9
|
$11-$25k
| 0
| 28,500
| null | null | 12
|
white
| 26
| 32
| 0.745972
| 0.665894
| 4
| 0
| 0
|
no
| 0.85
| 0.75
|
no dnr
| 11
| 103
| 14.798828
| 64
| 27
| 36.19531
| 227.5
| 4.599609
| 4.199219
| 3.799805
| 147
| 7.359375
| 196
| 104
| 1,120
| 1
| 4
|
<2 mo. follow-up
| 4
| 11
| 1
|
57.82599
|
female
| 1
| 13
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 12
|
$11-$25k
| 0
| 26,240
| null | null | 30
|
white
| 33.796875
| 51
| 0.42395
| 0.223999
| 1
| 0
| 0
|
yes
| 0.4
| 0.25
|
dnr after sadm
| 9
| 127
| 12
| 116
| 30
| 38
| 283.3125
| 2.599609
| 6.5
| 2.5
| 141
| 7.509766
| 142
| 68
| 1,585
| null | 6
|
<2 mo. follow-up
| 6
| 13
| 1
|
59.39798
|
male
| 0
| 17
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 13
|
$11-$25k
| 0
| 59,896
| null | null | 24.333328
|
white
| 27.597656
| 55
| 0.782959
| 0.652954
| 1
| 1
| 0
|
no
| 0.9
| 0.6
|
no dnr
| 17
| 124
| 17.898438
| 104
| 22
| 36.39844
| 267.5
| 2.399902
| 0.699951
| 0.399963
| 130
| 7.449219
| 111
| 15
| 1,175
| 1
| 0
|
adl>=4 (>=5 if sur)
| 0
| 86
| 1
|
68.40198
|
male
| 0
| 13
|
Colon Cancer
|
Cancer
| 4
| 16
|
>$50k
| 0
| 24,885
| null | null | 16.5
|
white
| 47
| 40
| 0.089996
| 0.003
| 1
| 1
| 0
|
metastatic
| 0.7
| 0.2
|
no dnr
| 13
| 123
| 10.099609
| 124
| 30
| 38
| 188.5625
| null | null | 1.199951
| 142
| 7.269531
| 124
| 29
| 2,745
| 5
| 1
|
<2 mo. follow-up
| 1
| 43
| 1
|
58.08398
|
female
| 1
| 11
|
Coma
|
Coma
| 1
| null | null | 100
| 59,286
| null | null | 26
|
black
| 24.199219
| 42
| 0.155975
| 0.102997
| 22
| 1
| 0
|
no
| 0.7
| 0.1
|
dnr after sadm
| 3
| 69
| 5.099609
| 60
| 16
| 36.59375
| null | null | 1.099854
| 1.399902
| 133
| null | 102
| 23
| 2,175
| null | 0
|
<2 mo. follow-up
| 0
| 11
| 1
|
77.24298
|
male
| 0
| 16
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 19
| null | 0
| 32,418
| null | null | 19.666656
|
white
| 26.898438
| 35
| 0.629883
| 0.44696
| 4
| 0
| 0
|
no
| 0.75
| 0.7
|
no dnr
| 16
| 81
| 8.599609
| 76
| 16
| 36
| null | 4
| 0.399963
| 0.899902
| 143
| null | 99
| 9
| null | null | 2
| null | 2
| 88
| 1
|
71.66296
|
male
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 11
|
under $11k
| 0
| 33,404
| null | null | 14
|
white
| 15.699219
| 8
| 0.850952
| 0.799927
| 8
| 1
| 0
|
no
| 0.5
| 0.5
|
dnr before sadm
| 0
| 50
| 15.398438
| 64
| 16
| 37.89844
| 314.25
| 3.199707
| null | 1.099854
| 137
| 7.429688
| 118
| 13
| 3,060
| null | 7
|
adl>=4 (>=5 if sur)
| 7
| 218
| 1
|
67.57599
|
male
| 0
| 10
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| null | null | 0
| 9,614
| null | null | 5.5
|
white
| 14.699219
| 16
| 0.87793
| 0.796997
| 1
| 0
| 0
|
yes
| null | null |
no dnr
| 10
| 71
| 7.899414
| 66
| 18
| 36.5
| 328.5625
| null | 0.699951
| 1.399902
| 140
| 7.40918
| 88
| 22
| null | null | null | null | 2.745117
| 1,029
| 1
|
47.51797
|
male
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 11
|
under $11k
| 9
| 30,760
| null | null | 16.5
|
black
| 29.296875
| 50
| 0.748901
| 0.669922
| 2
| 0
| 0
|
no
| 0.9
| 0.85
|
no dnr
| 13
| 121
| 6.599609
| 124
| 10
| 34.59375
| 186
| 1.899902
| 5.5
| 1
| 132
| 7.429688
| 268
| 15
| 2,350
| null | 0
|
adl>=4 (>=5 if sur)
| 0
| 1,029
| 0
|
26.045
|
male
| 0
| 31
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 9
| null | 0
| null | null | null | 40.75
|
black
| 41.5
| 80
| 0.587891
| 0.478943
| 1
| 0
| 0
|
yes
| 0.1
| 0.1
| null | null | 51
| 12
| 114
| 24
| 38.19531
| 276.625
| null | null | 3.399902
| 133
| 7.399414
| 296
| 57
| 3,085
| null | 5
|
no(M2 and SIP pres)
| 5
| 1,029
| 0
|
68.10394
|
female
| 0
| 19
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 8
|
under $11k
| 0
| 24,701
| null | null | 7
|
black
| 23.898438
| 30
| 0.802979
| 0.681885
| 1
| 1
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 19
| 66
| 95.296875
| 120
| 32
| 37.5
| 118.35938
| 2.799805
| 2.5
| 3.599609
| 142
| 7.329102
| 90
| 59
| 1,285
| 2
| 2
|
SIP>=30
| 2
| 1,029
| 0
|
88.20795
|
female
| 0
| 12
|
Coma
|
Coma
| 1
| null | null | 100
| 6,887
| null | null | 7.5
|
black
| 18.898438
| 28
| 0.134979
| 0.085999
| 1
| 0
| 0
|
no
| 0.05
| 0.02
|
dnr after sadm
| 1
| 147
| 8.898438
| 70
| 24
| 36.09375
| 404
| null | 0.899902
| 0.899902
| 142
| 7.40918
| 179
| 23
| 5,150
| null | 2
|
<2 mo. follow-up
| 2
| 23
| 1
|
65.84497
|
male
| 0
| 4
|
Lung Cancer
|
Cancer
| 1
| 5
|
$11-$25k
| 0
| 4,475
| null | null | null |
black
| 16.597656
| 11
| 0.69397
| 0.403992
| 2
| 0
| 0
|
metastatic
| 0.8
| 0.7
|
no dnr
| 4
| 55
| 7.899414
| 104
| 22
| 37.79688
| 122
| null | 0.5
| 1.299805
| 147
| 7.429688
| 191
| 15
| 1,975
| null | 0
| null | 0
| 61
| 1
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.